Fig. 2From: Pharmaceutical compounding and storage of faricimab in a syringe for intravitreal injection do not impair stability and bi-specific binding propertiesConcentrations of faricimab directly from the vial and after withdrawal and storage in the Zero Residual syringe. The figure shows both undiluted and diluted samples (diluted 1:100 in sterile PBS). n = 9 for all sample sets. **p = < 0.005, ns = non-significantBack to article page